Test spinal fluid tests to help identify brain tumor types
Part of Brain & nervous system, Cancer clinical trials.
This study looks at spinal fluid (cerebrospinal fluid, or CSF) to find markers that may signal a brain or spinal tumor or related abnormal growth. If you have a suspected tumor near the CSF spaces, these results may help doctors better classify what’s going on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You have medical or scan evidence of a growth in the brain/spine area that connects with spinal fluid (CSF)
- You must be able and willing to sign written informed consent (or have a legal representative if you can’t consent yourself)
- You must not be pregnant (or able to become pregnant) while joining the study
- Your doctor must say a CSF procedure is safe for you (for example, lumbar puncture may be unsafe with certain high-risk brain/spine findings or bleeding problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at proteins in the fluid around the brain and spinal cord (cerebrospinal fluid) to learn more about neurological conditions. Samples are collected during routine procedures, and leftover fluid is studied to find markers that may help diagnose or track these conditions.
This trial uses a small piece of your brain tumor after surgery to test which drugs might work best for you. It helps doctors find the most effective treatment for your specific tumor.
This study collects samples of spinal fluid and blood from people with solid tumours that have spread to the brain or spine, or who have primary brain tumours. The goal is see if these samples can help doctors detect and monitor these cancers more easily.
This study uses a simple spinal fluid test (liquid biopsy) to find and track how primary CNS lymphoma responds to treatment. The goal is to help doctors plan your care with fewer invasive procedures.
This study collects leftover brain or spinal tumor tissue during neurosurgery (or from autopsies) so researchers can test drugs and measure how they work. It may help future treatments by improving drug screening using real patient tissue.
This study collects spinal fluid samples from people with advanced (metastatic) HER2-positive or triple-negative breast cancer who have never had, and currently do not have, cancer spread to the brain. Researchers want to understand how cancer cells might reach the nervous system and develop better treatments.
Hear when a new Central Nervous System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.